Efficacy and safety of intravenous and oral diltiazem for Wolff-Parkinson-White syndrome
Identifieur interne :
001256 ( PascalFrancis/Corpus );
précédent :
001255;
suivant :
001257
Efficacy and safety of intravenous and oral diltiazem for Wolff-Parkinson-White syndrome
Auteurs : MOHAMMAD SHENASA ;
M. Fromer ;
G. Faugere ;
R. Nadeau ;
R. A. Leblanc ;
C. Lambert ;
MOHAMMAD ALI SADR-AMELISource :
-
American (The) journal of cardiology [ 0002-9149 ] ; 1987.
RBID : Pascal:87-0328994
Descripteurs français
English descriptors
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
| pA |
| A01 | 01 | 1 | | @0 0002-9149 |
|---|
| A03 | | 1 | | @0 Am. j. cardiol. |
|---|
| A05 | | | | @2 59 |
|---|
| A06 | | | | @2 4 |
|---|
| A08 | 01 | 1 | ENG | @1 Efficacy and safety of intravenous and oral diltiazem for Wolff-Parkinson-White syndrome |
|---|
| A11 | 01 | 1 | | @1 MOHAMMAD SHENASA |
|---|
| A11 | 02 | 1 | | @1 FROMER (M.) |
|---|
| A11 | 03 | 1 | | @1 FAUGERE (G.) |
|---|
| A11 | 04 | 1 | | @1 NADEAU (R.) |
|---|
| A11 | 05 | 1 | | @1 LEBLANC (R. A.) |
|---|
| A11 | 06 | 1 | | @1 LAMBERT (C.) |
|---|
| A11 | 07 | 1 | | @1 MOHAMMAD ALI SADR-AMELI |
|---|
| A14 | 01 | | | @1 Univ. Montreal, Sacré-Cœur hosp. @2 Montreal PQ H4J 1C5 @3 CAN @Z A11011000 |
|---|
| A20 | | | | @1 301-306 |
|---|
| A21 | | | | @1 1987 |
|---|
| A23 | 01 | | | @0 ENG |
|---|
| A43 | 01 | | | @1 CNRS @2 8674 |
|---|
| A44 | | | | @0 0000 |
|---|
| A45 | | | | @0 20 ref. |
|---|
| A47 | 01 | 1 | | @0 87-0328994 |
|---|
| A60 | | | | @1 P |
|---|
| A61 | | | | @0 A |
|---|
| A64 | | 1 | | @0 American (The) journal of cardiology |
|---|
| A66 | 01 | | | @0 USA |
|---|
| C02 | 01 | X | | @0 002B02F02 |
|---|
| C03 | 01 | X | FRE | @0 Diltiazem |
|---|
| C03 | 02 | X | FRE | @0 Antagoniste calcium |
|---|
| C03 | 03 | X | FRE | @0 Voie intraveineuse |
|---|
| C03 | 04 | X | FRE | @0 Voie orale |
|---|
| C03 | 05 | X | FRE | @0 Wolff Parkinson White syndrome |
|---|
| C03 | 06 | X | FRE | @0 Homme |
|---|
| C03 | 07 | X | FRE | @0 Chimiothérapie |
|---|
| C03 | 15 | X | FRE | @0 Trouble rythme cardiaque |
|---|
| C03 | 16 | X | FRE | @0 Appareil circulatoire pathologie |
|---|
| C03 | 02 | X | ENG | @0 Calcium antagonist |
|---|
| C03 | 03 | X | ENG | @0 Intravenous administration |
|---|
| C03 | 04 | X | ENG | @0 Oral administration |
|---|
| C03 | 05 | X | ENG | @0 Wolff Parkinson White syndrome |
|---|
| C03 | 06 | X | ENG | @0 Human |
|---|
| C03 | 07 | X | ENG | @0 Chemotherapy |
|---|
| C03 | 15 | X | ENG | @0 Arrhythmia |
|---|
| C03 | 16 | X | ENG | @0 Cardiovascular disease |
|---|
| C03 | 02 | X | SPA | @0 Calcio antagonista |
|---|
| C03 | 03 | X | SPA | @0 Via intravenosa |
|---|
| C03 | 04 | X | SPA | @0 Via oral |
|---|
| C03 | 05 | X | SPA | @0 Wolff Parkinson White sindrome |
|---|
| C03 | 06 | X | SPA | @0 Hombre |
|---|
| C03 | 07 | X | SPA | @0 Quimioterapia |
|---|
| C03 | 15 | X | SPA | @0 Arritmia |
|---|
| C03 | 16 | X | SPA | @0 Aparato circulatorio patologia |
|---|
| C04 | 01 | X | | @0 PU01!07,05 |
|---|
| C04 | 02 | X | | @0 PU05!07,01 |
|---|
| N21 | | | | @1 714 |
|---|
|
|---|
Format Inist (serveur)
| NO : | PASCAL 87-0328994 INIST |
|---|
| ET : | Efficacy and safety of intravenous and oral diltiazem for Wolff-Parkinson-White syndrome |
|---|
| AU : | MOHAMMAD SHENASA; FROMER (M.); FAUGERE (G.); NADEAU (R.); LEBLANC (R. A.); LAMBERT (C.); MOHAMMAD ALI SADR-AMELI |
|---|
| AF : | Univ. Montreal, Sacré-Cœur hosp./Montreal PQ H4J 1C5/Canada (A11011000) |
|---|
| DT : | Publication en série; Niveau analytique |
|---|
| SO : | American (The) journal of cardiology; ISSN 0002-9149; Etats-Unis; Da. 1987; Vol. 59; No. 4; Pp. 301-306; Bibl. 20 ref. |
|---|
| LA : | Anglais |
|---|
| CC : | 002B02F02 |
|---|
| FD : | Diltiazem; Antagoniste calcium; Voie intraveineuse; Voie orale; Wolff Parkinson White syndrome; Homme; Chimiothérapie; Trouble rythme cardiaque; Appareil circulatoire pathologie |
|---|
| ED : | Calcium antagonist; Intravenous administration; Oral administration; Wolff Parkinson White syndrome; Human; Chemotherapy; Arrhythmia; Cardiovascular disease |
|---|
| SD : | Calcio antagonista; Via intravenosa; Via oral; Wolff Parkinson White sindrome; Hombre; Quimioterapia; Arritmia; Aparato circulatorio patologia |
|---|
| LO : | CNRS-8674 |
|---|
| ID : | 87-0328994 |
|---|
Links to Exploration step
Pascal:87-0328994
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Efficacy and safety of intravenous and oral diltiazem for Wolff-Parkinson-White syndrome</title>
<author><name sortKey="Mohammad Shenasa" sort="Mohammad Shenasa" uniqKey="Mohammad Shenasa" last="Mohammad Shenasa">MOHAMMAD SHENASA</name>
</author><author><name sortKey="Fromer, M" sort="Fromer, M" uniqKey="Fromer M" first="M." last="Fromer">M. Fromer</name>
</author><author><name sortKey="Faugere, G" sort="Faugere, G" uniqKey="Faugere G" first="G." last="Faugere">G. Faugere</name>
</author><author><name sortKey="Nadeau, R" sort="Nadeau, R" uniqKey="Nadeau R" first="R." last="Nadeau">R. Nadeau</name>
</author><author><name sortKey="Leblanc, R A" sort="Leblanc, R A" uniqKey="Leblanc R" first="R. A." last="Leblanc">R. A. Leblanc</name>
</author><author><name sortKey="Lambert, C" sort="Lambert, C" uniqKey="Lambert C" first="C." last="Lambert">C. Lambert</name>
</author><author><name sortKey="Mohammad Ali Sadr Ameli" sort="Mohammad Ali Sadr Ameli" uniqKey="Mohammad Ali Sadr Ameli" last="Mohammad Ali Sadr-Ameli">MOHAMMAD ALI SADR-AMELI</name>
</author><publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">87-0328994</idno>
<date when="1987">1987</date>
<idno type="stanalyst">PASCAL 87-0328994 INIST</idno>
<idno type="RBID">Pascal:87-0328994</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001256</idno>
</publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Efficacy and safety of intravenous and oral diltiazem for Wolff-Parkinson-White syndrome</title>
<author><name sortKey="Mohammad Shenasa" sort="Mohammad Shenasa" uniqKey="Mohammad Shenasa" last="Mohammad Shenasa">MOHAMMAD SHENASA</name>
</author><author><name sortKey="Fromer, M" sort="Fromer, M" uniqKey="Fromer M" first="M." last="Fromer">M. Fromer</name>
</author><author><name sortKey="Faugere, G" sort="Faugere, G" uniqKey="Faugere G" first="G." last="Faugere">G. Faugere</name>
</author><author><name sortKey="Nadeau, R" sort="Nadeau, R" uniqKey="Nadeau R" first="R." last="Nadeau">R. Nadeau</name>
</author><author><name sortKey="Leblanc, R A" sort="Leblanc, R A" uniqKey="Leblanc R" first="R. A." last="Leblanc">R. A. Leblanc</name>
</author><author><name sortKey="Lambert, C" sort="Lambert, C" uniqKey="Lambert C" first="C." last="Lambert">C. Lambert</name>
</author><author><name sortKey="Mohammad Ali Sadr Ameli" sort="Mohammad Ali Sadr Ameli" uniqKey="Mohammad Ali Sadr Ameli" last="Mohammad Ali Sadr-Ameli">MOHAMMAD ALI SADR-AMELI</name>
</author><series><title level="j" type="main">American (The) journal of cardiology</title>
<title level="j" type="abbreviated">Am. j. cardiol.</title>
<idno type="ISSN">0002-9149</idno>
<imprint><date when="1987">1987</date>
</imprint><seriesStmt><title level="j" type="main">American (The) journal of cardiology</title>
<title level="j" type="abbreviated">Am. j. cardiol.</title>
<idno type="ISSN">0002-9149</idno>
</seriesStmt><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Arrhythmia</term>
<term>Calcium antagonist</term>
<term>Cardiovascular disease</term>
<term>Chemotherapy</term>
<term>Human</term>
<term>Intravenous administration</term>
<term>Oral administration</term>
<term>Wolff Parkinson White syndrome</term>
</keywords><keywords scheme="Pascal" xml:lang="fr"><term>Diltiazem</term>
<term>Antagoniste calcium</term>
<term>Voie intraveineuse</term>
<term>Voie orale</term>
<term>Wolff Parkinson White syndrome</term>
<term>Homme</term>
<term>Chimiothérapie</term>
<term>Trouble rythme cardiaque</term>
<term>Appareil circulatoire pathologie</term>
</keywords><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0002-9149</s0>
</fA01><fA03 i2="1"><s0>Am. j. cardiol.</s0>
</fA03><fA08 i1="01" i2="1" l="ENG"><s1>Efficacy and safety of intravenous and oral diltiazem for Wolff-Parkinson-White syndrome</s1>
</fA08><fA11 i1="01" i2="1"><s1>MOHAMMAD SHENASA</s1>
</fA11><fA11 i1="02" i2="1"><s1>FROMER (M.)</s1>
</fA11><fA11 i1="03" i2="1"><s1>FAUGERE (G.)</s1>
</fA11><fA11 i1="04" i2="1"><s1>NADEAU (R.)</s1>
</fA11><fA11 i1="05" i2="1"><s1>LEBLANC (R. A.)</s1>
</fA11><fA11 i1="06" i2="1"><s1>LAMBERT (C.)</s1>
</fA11><fA11 i1="07" i2="1"><s1>MOHAMMAD ALI SADR-AMELI</s1>
</fA11><fA14 i1="01"><s1>Univ. Montreal, Sacré-Cœur hosp.</s1>
<s2>Montreal PQ H4J 1C5</s2>
<s3>CAN</s3>
<sZ>A11011000</sZ>
</fA14><fA20><s1>301-306</s1>
</fA20><fA21><s1>1987</s1>
</fA21><fA23 i1="01"><s0>ENG</s0>
</fA23><fA43 i1="01"><s1>CNRS</s1>
<s2>8674</s2>
</fA43><fA44><s0>0000</s0>
</fA44><fA45><s0>20 ref.</s0>
</fA45><fA47 i1="01" i2="1"><s0>87-0328994</s0>
</fA47><fA64 i2="1"><s0>American (The) journal of cardiology</s0>
</fA64><fA66 i1="01"><s0>USA</s0>
</fA66><fC02 i1="01" i2="X"><s0>002B02F02</s0>
</fC02><fC03 i1="01" i2="X" l="FRE"><s0>Diltiazem</s0>
</fC03><fC03 i1="02" i2="X" l="FRE"><s0>Antagoniste calcium</s0>
</fC03><fC03 i1="03" i2="X" l="FRE"><s0>Voie intraveineuse</s0>
</fC03><fC03 i1="04" i2="X" l="FRE"><s0>Voie orale</s0>
</fC03><fC03 i1="05" i2="X" l="FRE"><s0>Wolff Parkinson White syndrome</s0>
</fC03><fC03 i1="06" i2="X" l="FRE"><s0>Homme</s0>
</fC03><fC03 i1="07" i2="X" l="FRE"><s0>Chimiothérapie</s0>
</fC03><fC03 i1="15" i2="X" l="FRE"><s0>Trouble rythme cardiaque</s0>
</fC03><fC03 i1="16" i2="X" l="FRE"><s0>Appareil circulatoire pathologie</s0>
</fC03><fC03 i1="02" i2="X" l="ENG"><s0>Calcium antagonist</s0>
</fC03><fC03 i1="03" i2="X" l="ENG"><s0>Intravenous administration</s0>
</fC03><fC03 i1="04" i2="X" l="ENG"><s0>Oral administration</s0>
</fC03><fC03 i1="05" i2="X" l="ENG"><s0>Wolff Parkinson White syndrome</s0>
</fC03><fC03 i1="06" i2="X" l="ENG"><s0>Human</s0>
</fC03><fC03 i1="07" i2="X" l="ENG"><s0>Chemotherapy</s0>
</fC03><fC03 i1="15" i2="X" l="ENG"><s0>Arrhythmia</s0>
</fC03><fC03 i1="16" i2="X" l="ENG"><s0>Cardiovascular disease</s0>
</fC03><fC03 i1="02" i2="X" l="SPA"><s0>Calcio antagonista</s0>
</fC03><fC03 i1="03" i2="X" l="SPA"><s0>Via intravenosa</s0>
</fC03><fC03 i1="04" i2="X" l="SPA"><s0>Via oral</s0>
</fC03><fC03 i1="05" i2="X" l="SPA"><s0>Wolff Parkinson White sindrome</s0>
</fC03><fC03 i1="06" i2="X" l="SPA"><s0>Hombre</s0>
</fC03><fC03 i1="07" i2="X" l="SPA"><s0>Quimioterapia</s0>
</fC03><fC03 i1="15" i2="X" l="SPA"><s0>Arritmia</s0>
</fC03><fC03 i1="16" i2="X" l="SPA"><s0>Aparato circulatorio patologia</s0>
</fC03><fC04 i1="01" i2="X"><s0>PU01!07,05</s0>
</fC04><fC04 i1="02" i2="X"><s0>PU05!07,01</s0>
</fC04><fN21><s1>714</s1>
</fN21><server><NO>PASCAL 87-0328994 INIST</NO>
<ET>Efficacy and safety of intravenous and oral diltiazem for Wolff-Parkinson-White syndrome</ET>
<AU>MOHAMMAD SHENASA; FROMER (M.); FAUGERE (G.); NADEAU (R.); LEBLANC (R. A.); LAMBERT (C.); MOHAMMAD ALI SADR-AMELI</AU>
<AF>Univ. Montreal, Sacré-Cœur hosp./Montreal PQ H4J 1C5/Canada (A11011000)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>American (The) journal of cardiology; ISSN 0002-9149; Etats-Unis; Da. 1987; Vol. 59; No. 4; Pp. 301-306; Bibl. 20 ref.</SO>
<LA>Anglais</LA>
<CC>002B02F02</CC>
<FD>Diltiazem; Antagoniste calcium; Voie intraveineuse; Voie orale; Wolff Parkinson White syndrome; Homme; Chimiothérapie; Trouble rythme cardiaque; Appareil circulatoire pathologie</FD>
<ED>Calcium antagonist; Intravenous administration; Oral administration; Wolff Parkinson White syndrome; Human; Chemotherapy; Arrhythmia; Cardiovascular disease</ED>
<SD>Calcio antagonista; Via intravenosa; Via oral; Wolff Parkinson White sindrome; Hombre; Quimioterapia; Arritmia; Aparato circulatorio patologia</SD>
<LO>CNRS-8674</LO>
<ID>87-0328994</ID>
</server>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001256 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001256 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= PascalFrancis
|étape= Corpus
|type= RBID
|clé= Pascal:87-0328994
|texte= Efficacy and safety of intravenous and oral diltiazem for Wolff-Parkinson-White syndrome
}}
| This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022 |  |
